BG
SPPI

BlackRock Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

BlackRock Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$855K Buy
192,939
+45,233
+31% +$190K ﹤0.01% 2198
2016
Q3 		$689K Buy
147,706
+31,116
+27% +$184K ﹤0.01% 2196
2016
Q2 		$766K Sell
116,590
-3,313
-3% -$23.4K ﹤0.01% 2089
2016
Q1 		$763K Buy
119,903
+4,097
+4% +$21K ﹤0.01% 2062
2015
Q4 		$699K Sell
115,806
-234
-0.2% -$1.34K ﹤0.01% 2069
2015
Q3 		$693K Sell
116,040
-3,613
-3% -$25.1K ﹤0.01% 2075
2015
Q2 		$819K Buy
119,653
+15,412
+15% +$97.9K ﹤0.01% 2056
2015
Q1 		$633K Buy
104,241
+9,789
+10% +$65.1K ﹤0.01% 2095
2014
Q4 		$655K Buy
94,452
+4,551
+5% +$33.5K ﹤0.01% 2122
2014
Q3 		$732K Sell
89,901
-1,919
-2% -$15K ﹤0.01% 1971
2014
Q2 		$746K Sell
91,820
-24,593
-21% -$187K ﹤0.01% 2013
2014
Q1 		$912K Buy
116,413
+4,681
+4% +$39.6K ﹤0.01% 2028
2013
Q4 		$989K Buy
111,732
+8,192
+8% +$73.2K ﹤0.01% 1968
2013
Q3 		$868K Buy
103,540
+27,862
+37% +$226K ﹤0.01% 1988
2013
Q2 		$565K Buy
+75,678
New +$581K ﹤0.01% 2027

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Group's SPPI Position: Q4 2016 in Review

BlackRock Group increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 31% in Q4 2016, buying an estimated $190K and bringing the position to 192,939 shares worth $855K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

BlackRock Group first reported a position in SPPI in Q2 2013 and has held it in 15 quarters since. The position peaked at $989K in Q4 2013. 139 funds tracked by Wall St. Rank hold SPPI as of Q4 2016.

  • BlackRock Group held 192,939 shares of Spectrum Pharmaceuticals Inc worth $855K as of Q4 2016.
  • BlackRock Group bought 45,233 Spectrum Pharmaceuticals Inc shares in Q4 2016, an estimated $190K.
  • Spectrum Pharmaceuticals Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2198 holding.
  • BlackRock Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Spectrum Pharmaceuticals Inc position peaked at $989K in Q4 2013.
  • 139 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.